GILEAD SCIENCES INC Insider Trading for March 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC for March 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 20.74 | 50,000 | 1,037,000 | 90,000 | |
Mar 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 16.40 | 20,000 | 327,900 | 0 | |
Mar 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 101.18 | 37,903 | 3,834,938 | 165,168 | 203.1 K to 165.2 K (-18.66 %) |
Mar 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 100.36 | 32,097 | 3,221,268 | 203,071 | 235.2 K to 203.1 K (-13.65 %) |
Mar 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 20.74 | 50,000 | 1,037,000 | 235,168 | 185.2 K to 235.2 K (+27.00 %) |
Mar 18 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 16.40 | 20,000 | 327,900 | 185,168 | 165.2 K to 185.2 K (+12.11 %) |
Mar 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 80.65 | 2,000 | 161,300 | 34,640 | |
Mar 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 104.18 | 2,000 | 208,364 | 45,439 | 47.4 K to 45.4 K (-4.22 %) |
Mar 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 80.65 | 2,000 | 161,300 | 47,439 | 45.4 K to 47.4 K (+4.40 %) |
Mar 04 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 19.09 | 10,000 | 190,850 | 44,375 | |
Mar 04 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 104.12 | 200 | 20,824 | 147,422 | 147.6 K to 147.4 K (-0.14 %) |
Mar 04 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 103.36 | 1,800 | 186,045 | 147,622 | 149.4 K to 147.6 K (-1.20 %) |
Mar 04 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 104.21 | 1,393 | 145,169 | 149,422 | 150.8 K to 149.4 K (-0.92 %) |
Mar 04 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 103.59 | 8,607 | 891,577 | 150,815 | 159.4 K to 150.8 K (-5.40 %) |
Mar 04 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 19.09 | 10,000 | 190,850 | 159,422 | 149.4 K to 159.4 K (+6.69 %) |
Mar 04 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 14.50 | 150,000 | 2,175,375 | 1,350,000 | |
Mar 04 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 103.51 | 150,000 | 15,526,245 | 4,255,876 | 4.4 M to 4.3 M (-3.40 %) |
Mar 04 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 14.50 | 150,000 | 2,175,375 | 4,405,876 | 4.3 M to 4.4 M (+3.52 %) |
Mar 03 2015 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | M | 26.99 | 5,000 | 134,950 | 0 | |
Mar 03 2015 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Sell | S | 103.43 | 5,000 | 517,136 | 15,641 | 20.6 K to 15.6 K (-24.22 %) |
Mar 03 2015 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Buy | M | 26.99 | 5,000 | 134,950 | 20,641 | 15.6 K to 20.6 K (+31.97 %) |
Mar 03 2015 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | M | 0.00 | 167 | 0 | 23,728 | |
Mar 03 2015 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Buy | M | 0.00 | 167 | 0 | 15,119 | 15 K to 15.1 K (+1.12 %) |